XML 53 R41.htm IDEA: XBRL DOCUMENT v3.20.2
ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. - Narrative (Detail) - USD ($)
2 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2018
Nov. 23, 2018
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2019
Dec. 31, 2018
Jul. 20, 2018
Business Acquisition [Line Items]                
Goodwill impairments     $ 0 $ 0        
Sangamo France | Share Purchase Agreement and Tender Offer Agreement                
Business Acquisition [Line Items]                
Noncontrolling interest ownership percentage     99.40%     98.70%    
Sangamo France                
Business Acquisition [Line Items]                
Number of ordinary shares acquired (in shares) 13,519,036 11,528,635            
Business acquisition, percentage of voting interests acquired             98.20%  
Consideration transferred $ 45,900,000              
Business acquisition, share price (in dollars per share) $ 2.99              
Sangamo France | Share Purchase Agreement and Tender Offer Agreement                
Business Acquisition [Line Items]                
Percentage of equity interests agreed to acquire               100.00%
Number of ordinary shares acquired (in shares)     228,000   25,047,671 111,000    
Number of free shares held by the holders (in shares)               477,000
Cash paid for shares acquired     $ 500,000          
Estimated fair value liability of free shares           $ 200,000   $ 200,000
Estimated fair value asset of free shares     $ 100,000          
Sangamo France | Share Purchase Agreement and Tender Offer Agreement | Executive Officer                
Business Acquisition [Line Items]                
Number of ordinary shares acquired (in shares)     132,700          
Sangamo France | Share Purchase Agreement and Tender Offer Agreement | Option Pricing Method                
Business Acquisition [Line Items]                
Estimated fair value liability of free shares $ 200,000